Key facts
- Vulgaroo’s last known valuation is $6.6M (Dec 2025).
- It has raised $580K; the latest was Seed Round ($580K) in Dec 2025.
- Notable investors include Bpifrance, Angels Santé, OVHcloud Startup Program, Unitec (Accelerator/Incubator).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Vulgaroo
- ·The full record, as it builds
Funding rounds
No funding rounds for Vulgaroo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vulgaroo
Developer of an AI-based medical report platform designed to translate scientific texts into words. The company's platform offers neural networks specialized in the simplification and translation of scientific texts, along with tools to assess the quality of the texts generated and their readability by people without scientific knowledge, enabling users to understand their health condition and make informed choices, in relation to their caregivers and the therapeutic decisions they wish to take.
- Sector
- Healthcare
- HQ
- Bordeaux, France
- Founded
- 2022
- Employees
- 10
- Website
- vulgaroo.com/
- Ownership
- Privately Held (backing)
Vulgaroo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vulgaroo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vulgaroo in its N-PORT filings yet. We sweep new filings monthly.